# SymBiosis: portfolio, investments and team > SymBiosis is a vc firm based in United States. 5 investments on record, 2 in the last 12 months, latest Jul 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/symbiosis (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # SymBiosis Last cheque observed Jul 2026; 5 cheques on record. Email VC firm Deploying now Series A Series B Biotechnology Therapeutics Life Sciences Follow SymBiosis and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fsymbiosis) Deploying now **100%** of best year **2** **cheques in 12 months**, 5 on record Since the last cheque **121** days **00** hrs **00** min **00** sec Median round **$67M** Rounds led **2 of 5** Mostly in **United States, 80%** Pitch SymBiosis ## SymBiosis highlights - 01 2 cheques in the last 12 months - 02 Mostly Series C and Series A: 80% of its rounds - 03 Led 2 rounds ## What they do > We partner with innovators building groundbreaking companies with the following characteristics Life-Threatening Disease With Hard Endpoint... Novel Therapeutic Platform In Any Modality... Lead Reaching Human Proof-Of-Concept... Designed for manufacturability From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Series A Series B - **Sectors:** Biotechnology Therapeutics Life Sciences - **Based in:** Bentonville, United States - **Cold pitches:** Accepted ## The record Every round we can evidence, newest first **5 appearances** - **2026** 2 rounds - **Jul** **[FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics)** Series D · US · Ventureburn **$67M** *Led* - **Mar** **[R1 Therapeutics](https://millionrounds.com/company/r1-therapeutics)** Series A · US · TechStartups **$78M** With 5 others - **2025** 1 round - **Feb** **[AdvanCell](https://millionrounds.com/company/advancell)** Series C · AU · Startup Daily **$112M** *Led* - **2019** 2 rounds - **Sept** **[Vedanta Biosciences](https://millionrounds.com/company/vedanta-biosciences)** Series C · US · FinSMEs **$17M** With 2 others - **May** **[Vedanta Biosciences](https://millionrounds.com/company/vedanta-biosciences)** Series C · US · Businesswire **$46M** With 8 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **6** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## The cheque Series A Series B Median round joined **$67M** the round, not its cheque Led 2 of 5 rounds **40%** - **Sole investor:** Never alone - **Last cheque:** Jul 2026 Rounds by stage said on their site - Series C *3* - Series A said *1* - Series D *1* - Series B said *-* Cheques by month Led Joined Dec 2023 Nov 2026 Often in the room with - [Abingworth](https://millionrounds.com/fund/abingworth) 2 **Pitching SymBiosis?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as SymBiosis. A count of rooms they were both in, not a relationship either has claimed. [**Abingworth** VC firm **2** rounds together](https://millionrounds.com/fund/abingworth) ## Recently backed The latest companies SymBiosis put money into. [**FORE Biotherapeutics** $67M · Jul 2026](https://millionrounds.com/company/fore-biotherapeutics)[**AdvanCell** $112M · Feb 2025](https://millionrounds.com/company/advancell)[**Vedanta Biosciences** $17M · Sept 2019](https://millionrounds.com/company/vedanta-biosciences) ## Quick answers about SymBiosis ### What does SymBiosis invest in? SymBiosis invests most often at Series C and Series A (80% of the rounds on record), in sectors such as Biotechnology, Therapeutics and Life Sciences. ### How active is SymBiosis? 5 investments on record, 2 of them in the last 12 months, and it led 2. The most recent was in Jul 2026. ### What has SymBiosis invested in recently? Its most recent investments on record: FORE Biotherapeutics (Series D, Jul 2026), R1 Therapeutics (Series A, Mar 2026) and AdvanCell (Series C, Feb 2025). ### How big are SymBiosis's cheques? The median round it joins is $67M. ### Does SymBiosis lead rounds? Yes: it led 2 of its 5 investments on record (40%). ### Where does SymBiosis invest? Most of the companies it backs are in the United States (80%) and Australia (20%). ### Is SymBiosis investing now? Yes: it is actively investing, with 2 investments in the last 12 months. ### Who does SymBiosis invest alongside? Most often Abingworth (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=symbiosis) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=symbiosis)